RWM
TBPH icon

Rialto Wealth Management’s Theravance Biopharma TBPH Stock Holding History

Rialto Wealth Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$527 Buy
+31
New +$513 ﹤0.01% 1678

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Rialto Wealth Management's TBPH Position: Q2 2026 in Review

Rialto Wealth Management opened a new position in Theravance Biopharma (TBPH) in Q2 2026: 31 shares worth $527. The stake represents ﹤0.01% of the portfolio and ranks #1678 among its holdings.

181 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Rialto Wealth Management held 31 shares of Theravance Biopharma worth $527 as of Q2 2026.
  • Theravance Biopharma was a new Rialto Wealth Management position in Q2 2026.
  • Theravance Biopharma made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1678 holding.
  • 181 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.